Home
News
Create
Screeners
Insights
Mercury Laboratories
847.
55
+12.05
(+1.44%)
Market Cap
₹- Cr
PE Ratio
-
Industry
Healthcare
Buy
Sell
Company Performance:
1D
+1.44%
1M
+0.90%
6M
-1.05%
1Y
-10.15%
5Y
+72.99%
View Company Insights
Latest news about Mercury Laboratories
Mercury Laboratories Postpones New Injectable Plant Commissioning to December 2026
Nov 12, 2025
Mercury Laboratories has postponed the commissioning of its new Small Volume Parenteral (SVPs) manufacturing plant from November 2025 to December 2026, citing revisions in Schedule M guidelines by the Ministry of Health and Family Welfare. The facility, located at Jarod, has a planned annual capacity of 75 million units with an investment of INR 30.00 crores. The company states the delay will not materially impact overall business operations. Recent financial results show significant year-over-year growth in both quarterly and half-yearly net profits.
Mercury Laboratories Reports 70% Surge in Q2 Net Profit, Revenue Up 4.8%
Nov 12, 2025
Mercury Laboratories Appoints Seema Salvi as Head of Injectable Production Department
Nov 04, 2025
Mercury Laboratories Reports 183% Jump in Net Profit with Strong Revenue Growth
Aug 13, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/Block Deals
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation